Healthcare -
Biotechnology - NASDAQ - US
$ 2.4325
3.07 %
$ 172 M
Market Cap
-1.33
P/E
NKTX - COST OF REVENUE
Cost of Revenue NKTX - Nkarta, Inc.
5.87 M
LAST VALUE
66.27%
2 YEAR CAGR
6.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR